ARTICLE | Clinical News
Acelex polmacoxib regulatory update
February 16, 2015 8:00 AM UTC
South Korea's Ministry of Food and Drug Safety (MFDS) approved an NDA from CrystalGenomics for Acelex polmacoxib to treat osteoarthritis. The product is a dual-acting cyclooxygenase-2 (COX-2) and car...